FDA Software Development
FDA Software Development
30
25
20
15
10
5
0
83 84 85 86 87 88 89 90 91 92 93 94 95 96
Year
SOFTWARE RECALLS
BY DEVICE PANEL
Radiology
InVitro Diagnostic
Cardiovascular
Anesthesiology 1983-91
Other
21 CFR 830.30
21 CFR 830.30 (a) (2) (i)
21 CFR 830.30 (g)
21 CFR 830.70 (i)
21 CFR 820.30 Design Controls
• Each manufacturer of any Class II or Class
III device, and the Class I devices listed in
paragraph (a)(2) of this section, shall
establish and maintain procedures to control
the design of the device in order to ensure
that the specified design requirements are
meet.
21 CFR 820.30 (a)(2)(i)
• Class I
– The following Class I devices are subject to
design controls:
• Devices automated with computer software
21 CFR 820.30 (g)
• Design validation shall include software
validation and risk analysis where
appropriate
21 CFR 820.70 (i)
• Automated processes
– When computers or automated data processing
systems are used as part of production or the
quality system, the manufacturer shall validate
computer software for its intended use
according to an established protocol. All
software changes shall be validated before
approval and issuance. These validation
activities shall be documented.
What is the goal?
• By Law: Medical Devices must be
reasonable safe and effective
• By default: Software must be safe and
effective
Safe and Effective
• It depends!
• Cannot be easily defined
• What is safe and effective software
– Software Engineering
– Risk Management
– Quality System
CDRH Software Message
• The law and regulations are written in broad
terms
• Software should be engineered using:
– Software Engineering
– Risk Management
– Quality System
This is the CDRH Software Message
Part 2
Regulatory
Overview
a c d e f g h j l p q t
b i k m r u
n s v
o
a. Guide to Computerized Systems in Drug Processing
b. Software Development Activities Reference Materials and Training Aids for Investigators
c. Draft FDA Policy for the Regulation of Computer Products
d. Draft Application of the Medical Device GMPs to Computerized Devices and Manufacturing Processes (Final 1992)
e. Draft Guidance for the Content and Review of 510(k) Notifications for Picture Archiving and Communications Systems(PACS)
and Related Devices
f. Reviewer Guidance for Computer Controlled Medical Devices Undergoing 510(k) Review
g. Draft Guideline for the Validation of Blood Establishment Computer Systems (Version 1 issued Oct-94)
h. Letter requiring submissions for Blood Bank Information Systems
i. Proposed Electronic Records: Electronic Signatures Rule
j. Glossary of Computerized System and Software Development Terminology
k. CADx Initiative
l. Telemedicine Related Activities Report
m. Public FDA Software Policy Workshop
n. Public Draft ODE Guidance for the Content of Premarket Submission for Medical Devices Containing Software
o. New Quality System Regulation
p. Do It By Design
q. Blood Bank Software Submission Guidance
r. Software Quality Audit Initiative
s. Final Rule Electronic Records: Electronic Signatures
t. General Principles of Software Validation - Draft Guidance
u. Guidance for Off-the-Shelf (OTS) Software Use in Medical Devices - Draft
v. Letter to Manufacturers Regarding the Year 2000 Computer Problem
Documents to date